Adenosine A2B receptors:: a novel therapeutic target in asthma?

被引:160
|
作者
Feoktistov, I
Polosa, R
Holgate, ST
Biaggioni, I
机构
[1] Vanderbilt Univ, Div Cardiol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[4] Univ Southampton, Div Immunopharmacol, Southampton SO16 6YD, Hants, England
关键词
D O I
10.1016/S0165-6147(98)01179-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine is an endogenous nucleoside that modulates many physiological processes. Its actions are mediated by interaction with specific cell membrane receptors. Four subtypes of adenosine receptor have been cloned: A(1), A(2A), A(2B) and A(3). Significant advancement has been made in our understanding of the molecular pharmacology and physiological relevance of adenosine receptors but our knowledge of A(2B), receptors lags behind that of other receptor types. Only recently have potentially important functions been discovered for the A(2B) receptors, prompting a renewed interest in this receptor type. A(2B) receptors have been implicated in the regulation of vascular smooth muscle tone, cell growth, intestinal function and neurosecretion. In this review, Igor Feoktistov, Riccardo Polesa, Stephen Holgate and Italo Biaggioni focus on the role of A(2B) receptors in mast cell activation and the potential relevance of this action on asthma.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 50 条
  • [1] The identification of the adenosine A2B receptor as a novel therapeutic target in asthma
    Holgate, ST
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (08) : 1009 - 1015
  • [2] Adenosine A2B receptors as therapeutic targets
    Feoktistov, I
    Wells, JN
    Biaggioni, I
    [J]. DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 198 - 206
  • [3] Adenosine A2B receptors
    Feoktistov, I
    Biaggioni, I
    [J]. PHARMACOLOGICAL REVIEWS, 1997, 49 (04) : 381 - 402
  • [4] The A2B adenosine receptor: an emerging therapeutic target in cancer
    Morello, Silvana
    Sorrentino, Claudia
    Pinto, Aldo
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [5] A2B adenosine receptors: novel tools and new roles
    Mueller, Christa
    [J]. PURINERGIC SIGNALLING, 2018, 14 : S28 - S28
  • [6] A novel and selective fluorescent ligand for the study of adenosine A2B receptors
    Patera, Foteini
    Mistry, Sarah J.
    Kindon, Nicholas D.
    Comeo, Eleonora
    Goulding, Joelle
    Kellam, Barrie
    Kilpatrick, Laura E.
    Franks, Hester
    Hill, Stephen J.
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (04):
  • [7] Adenosine A2B receptors in cancer cells
    Klotz, Karl-Norbert
    [J]. PURINERGIC SIGNALLING, 2010, 6 (01) : 66 - 67
  • [8] A2B adenosine receptors in immunity and inflammation
    Hasko, Gyoergy
    Csoka, Balazs
    Nemeth, Zoltan H.
    Vizi, E. Sylvester
    Pacher, Pal
    [J]. TRENDS IN IMMUNOLOGY, 2009, 30 (06) : 263 - 270
  • [9] Heteromerization of adenosine A2A and A2B receptors
    Hinz, Sonja
    Seibt, Benjamin F.
    Schiedel, Anke C.
    Franco, Rafael
    Mueller, Christa E.
    [J]. PURINERGIC SIGNALLING, 2014, 10 (04) : 756 - 756
  • [10] Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
    Asano, Teita
    Takenaga, Mitsuko
    [J]. JOURNAL OF CLINICAL MEDICINE, 2017, 6 (11):